Delivery Order SPE2DB25D3012-SPE2DB26FWVTE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of INBRIJA 42 mg inhalation capsules (60-count units) with a ceiling value of $1,941.36. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by May 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,941.36 for INBRIJA 42 mg inhalation capsules (60-count) by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price, competitively awarded procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- This delivery order, valued at $3,882.72, awards AmerisourceBergen Drug Corp the supply of INBRIJA 42 MG inhalation capsules (60-count units) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on September 16, 2025, without a set-aside designation, indicating the contract was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $2,502 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,694,800 INBRIJA 42 MG INHALATION CAP 60S. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one thousand two hundred fifty-one dollars to Amerisourcebergen Drug Corporation for INBRIJA 42 MG inhalation capsules. Under this order, Amerisourcebergen will deliver sixty capsules to a location in Conshohocken, Pennsylvania by mid-October to support the Defense Logistics Agency's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen frequently receives such small dollar, short-term...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,294.24 firm-fixed-price delivery order is for the supply of INBRIJA 42 MG INHALATION CAP 60S, a prescription medication. The contract has a performance period through June 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, with a potential value of $1,251.00 and a completion date of March 21, 2024. The contract does not have a set-aside designation....
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $1,251, this order is for the supply of 60 units of INBRIJA 42 MG inhalation capsules to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. No set aside designation was applied to this award to...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $1,876.50 to supply 60 units of the 42 mg Inbrija inhalation capsules. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by January 10, 2024. No set-aside designation was applied to this order, which was awarded against an existing indefinite-delivery contract between Amerisourcebergen Drug Corp...
- The Defense Logistics Agency Troop Support Medical awarded a $1,876.50 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 60 INBRIJA 42 MG inhalation capsules. The place of performance for this order is Conshohocken, Pennsylvania. The order period runs from September 25, 2023 through October 17, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, this order was likely...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVTEDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $1,294.24 to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count), with an ultimate completion date of November 26, 2025. This non-set-aside competitive award was issued on November 4, 2025, under firm fixed pricing terms. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a wide range of medications and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. As a critical vendor within the DLA Medical Supply Chain, the company fulfills diverse pharmaceutical requirements including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The company's competitive performance through numerous federal awards demonstrates its capability to meet stringent federal procurement standards and support the Defense Health Agency and related government healthcare systems efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/4/25 |